GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (LTS:0HF3) » Definitions » Institutional Ownership

Cencora (LTS:0HF3) Institutional Ownership : 68.76% (As of May. 24, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Cencora Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cencora's institutional ownership is 68.76%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cencora's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cencora's Float Percentage Of Total Shares Outstanding is 74.18%.


Cencora Institutional Ownership Historical Data

The historical data trend for Cencora's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora Institutional Ownership Chart

Cencora Historical Data

The historical data trend for Cencora can be seen below:

2021-05-31 2021-06-30 2021-07-31 2021-08-31 2021-09-30 2021-10-31 2021-11-30 2021-12-31 2022-01-31 2022-02-28
Institutional Ownership 62.38 64.56 63.62 63.64 67.92 68.22 67.54 67.63 68.02 68.76

Cencora Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Cencora (LTS:0HF3) Business Description

Traded in Other Exchanges
Address
1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Cencora (LTS:0HF3) Headlines

No Headlines